Acro Biomedical Co annual gross margin
2017
2018
2019
2019
2020
2021
2022
Acro Biomedical Co's gross margin was 21.34% for fiscal 2022.
View full Acro Biomedical Co company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | 21.34% | −0.33 pp |
| 2021 | 2021-12-31 | 21.67% | −1.50 pp |
| 2020 | 2020-12-31 | 23.17% | +16.92 pp |
| 2019 · Dec 31 | 2019-12-31 | 6.25% | −3.75 pp |
| 2019 · Sep 30 | 2019-09-30 | 10.00% | −0.40 pp |
| 2018 | 2018-09-30 | 10.40% | +0.40 pp |
| 2017 | 2017-09-30 | 10.00% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q4 2022 | 2022-12-31 | 17.78% | −11.87 pp |
| Q1 2022 | 2022-03-31 | 25.63% | +2.46 pp |
| Q4 2021 | 2021-12-31 | 25.08% | +15.08 pp |
| Q2 2021 | 2021-06-30 | 16.00% | +5.50 pp |
| Q1 2021 | 2021-03-31 | 29.65% | +18.74 pp |
| Q1 2020 | 2020-03-31 | 23.17% | +13.17 pp |
| Q1 2019 | 2018-12-31 | 10.00% | 0.00 pp |
| Q4 2018 | 2018-09-30 | 10.50% | — |
| Q3 2018 | 2018-06-30 | 10.91% | — |
| Q2 2018 | 2018-03-31 | 10.00% | — |
| Q1 2018 | 2017-12-31 | 10.00% | — |
Over the last five reported fiscal years, Acro Biomedical Co's gross margin increased from 10.40% to 21.34%, a change of +10.94 percentage points. The latest reported quarter, Q4 2022, shows 17.78%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Acro Biomedical Co filings at SEC.gov ↗